Complex Asset Search & Evaluation on Autopilot
Enterprise-grade AI to help spot the right opportunities, faster
It's time to work differently
The landscape of assets in biopharma grows more complex every minute. No team can process it all fast enough to consistently spot the right opportunities at the right time.
Legacy databases are static — they don't help with the real work. And generic AI tools hallucinate and only touch narrow slices of the landscape, leaving critical gaps.
Robo is purpose-built for end-to-end automation of nuanced, mission-critical research on external assets. And we're just getting started.
Search & evaluation, simplified.
Create a project
Outline your objectives in natural language — even complex, multi-part criteria. Robo automatically converts your mandate to fully tailored search and evaluation AI agents.
Search & Score
AI agents research across 100M+ primary data sources — including publications, trial registries, patents, and conference abstracts. Each asset is evaluated against your custom criteria with PhD-level rigor, then scored for relevance.
Review & Refine
Scan the top results, adjust parameters, and easily refine your shortlist of assets. Your feedback is incorporated instantly, sharpening the AI agents to reflect even more of your perspective and priorities.
Stay Current
Receive ongoing updates and refreshed asset profiles as new data becomes available. Robo ensures your brief stays active over time, so evaluations remain accurate and up to date.
We know Biopharma.
We know AI.
Our team has built successful companies at the intersection of biotech and artificial intelligence. We understand both the science and the business — and we've designed Robo specifically for how business teams in biopharma actually operate.
Ready to see the difference?